Loading…
Adherence of adolescents with cystic fibrosis to enzyme replacement therapy: associated factors
This article sets out to evaluate the prevalence and factors associated with adherence to enzyme replacement therapy among adolescents with cystic fibrosis. It is a cross-sectional, descriptive and observational study. Sociodemographic and clinical data were collected. The instruments used to assess...
Saved in:
Published in: | Ciência & saude coletiva 2019-12, Vol.24 (12), p.4717 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | Portuguese |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 12 |
container_start_page | 4717 |
container_title | Ciência & saude coletiva |
container_volume | 24 |
creator | Ferreira, Danielle Portella Chaves, Célia Regina Moutinho de Miranda Costa, Ana Carolina Carioca da |
description | This article sets out to evaluate the prevalence and factors associated with adherence to enzyme replacement therapy among adolescents with cystic fibrosis. It is a cross-sectional, descriptive and observational study. Sociodemographic and clinical data were collected. The instruments used to assess adherence were: the Morisky-Green questionnaire and medication dispensation at the pharmacy, and interviews with structured questionnaires for the associated factors. Forty-four adolescents were interviewed. According to the method of the pharmacy medication dispensation analysis and the Morisky-Green questionnaire, the adherence of 45.5% and 11.4% was found, respectively. The higher adherence was observed in those with early diagnosis and the lowest in older adolescents and girls. The factors with the highest prevalence of non-adherence were: not taking enzymes when eating out of the home; only taking enzymes with major meals; normal lung function; with severe and very severe obstruction. The prevalence of adhesion to enzymes was low. Information related to the disease and treatment should be improved, especially among older adolescents and with impairment of lung function, with the creation of strategies and longitudinal studies to identify factors that interfere with adherence. |
doi_str_mv | 10.1590/1413-812320182412.31622017 |
format | article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_31778521</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>31778521</sourcerecordid><originalsourceid>FETCH-LOGICAL-p108t-a48503326315eab28918a8f8c1f649982c3da4f03955c150d898e25829463a203</originalsourceid><addsrcrecordid>eNo1j0tLAzEURoMgtlb_ggT3U3Nvkpkbd6X4goIbXZc0c0NH5sUkIuOvt6CuPg4cDnxC3IJag3XqDgzoggA1KiA0gGsNJZ6gOhNLKCsqjC1hIS5T-lAKK23wQiw0VBVZhKXYb-ojT9wHlkOUvh5aToH7nORXk48yzCk3QcbmMA2pSTIPkvvvuWM58dj6wN3JlfmU8ON8L31KQ2h85lpGH_IwpStxHn2b-PpvV-L98eFt-1zsXp9etptdMYKiXHhDVmmNpQbL_oDkgDxFChBL4xxh0LU3UWlnbQCranLEaAmdKbVHpVfi5rc7fh46rvfj1HR-mvf_T_UP5XBV7Q</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Adherence of adolescents with cystic fibrosis to enzyme replacement therapy: associated factors</title><source>SciELO Brazil</source><source>Publicly Available Content Database</source><creator>Ferreira, Danielle Portella ; Chaves, Célia Regina Moutinho de Miranda ; Costa, Ana Carolina Carioca da</creator><creatorcontrib>Ferreira, Danielle Portella ; Chaves, Célia Regina Moutinho de Miranda ; Costa, Ana Carolina Carioca da</creatorcontrib><description>This article sets out to evaluate the prevalence and factors associated with adherence to enzyme replacement therapy among adolescents with cystic fibrosis. It is a cross-sectional, descriptive and observational study. Sociodemographic and clinical data were collected. The instruments used to assess adherence were: the Morisky-Green questionnaire and medication dispensation at the pharmacy, and interviews with structured questionnaires for the associated factors. Forty-four adolescents were interviewed. According to the method of the pharmacy medication dispensation analysis and the Morisky-Green questionnaire, the adherence of 45.5% and 11.4% was found, respectively. The higher adherence was observed in those with early diagnosis and the lowest in older adolescents and girls. The factors with the highest prevalence of non-adherence were: not taking enzymes when eating out of the home; only taking enzymes with major meals; normal lung function; with severe and very severe obstruction. The prevalence of adhesion to enzymes was low. Information related to the disease and treatment should be improved, especially among older adolescents and with impairment of lung function, with the creation of strategies and longitudinal studies to identify factors that interfere with adherence.</description><identifier>EISSN: 1678-4561</identifier><identifier>DOI: 10.1590/1413-812320182412.31622017</identifier><identifier>PMID: 31778521</identifier><language>por</language><publisher>Brazil</publisher><subject>Adolescent ; Child ; Cross-Sectional Studies ; Cystic Fibrosis - diagnosis ; Cystic Fibrosis - therapy ; Early Diagnosis ; Enzyme Replacement Therapy - statistics & numerical data ; Female ; Humans ; Male ; Medication Adherence - statistics & numerical data ; Surveys and Questionnaires ; Young Adult</subject><ispartof>Ciência & saude coletiva, 2019-12, Vol.24 (12), p.4717</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-9456-3319 ; 0000-0002-2659-720X ; 0000-0002-6727-188X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31778521$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ferreira, Danielle Portella</creatorcontrib><creatorcontrib>Chaves, Célia Regina Moutinho de Miranda</creatorcontrib><creatorcontrib>Costa, Ana Carolina Carioca da</creatorcontrib><title>Adherence of adolescents with cystic fibrosis to enzyme replacement therapy: associated factors</title><title>Ciência & saude coletiva</title><addtitle>Cien Saude Colet</addtitle><description>This article sets out to evaluate the prevalence and factors associated with adherence to enzyme replacement therapy among adolescents with cystic fibrosis. It is a cross-sectional, descriptive and observational study. Sociodemographic and clinical data were collected. The instruments used to assess adherence were: the Morisky-Green questionnaire and medication dispensation at the pharmacy, and interviews with structured questionnaires for the associated factors. Forty-four adolescents were interviewed. According to the method of the pharmacy medication dispensation analysis and the Morisky-Green questionnaire, the adherence of 45.5% and 11.4% was found, respectively. The higher adherence was observed in those with early diagnosis and the lowest in older adolescents and girls. The factors with the highest prevalence of non-adherence were: not taking enzymes when eating out of the home; only taking enzymes with major meals; normal lung function; with severe and very severe obstruction. The prevalence of adhesion to enzymes was low. Information related to the disease and treatment should be improved, especially among older adolescents and with impairment of lung function, with the creation of strategies and longitudinal studies to identify factors that interfere with adherence.</description><subject>Adolescent</subject><subject>Child</subject><subject>Cross-Sectional Studies</subject><subject>Cystic Fibrosis - diagnosis</subject><subject>Cystic Fibrosis - therapy</subject><subject>Early Diagnosis</subject><subject>Enzyme Replacement Therapy - statistics & numerical data</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medication Adherence - statistics & numerical data</subject><subject>Surveys and Questionnaires</subject><subject>Young Adult</subject><issn>1678-4561</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNo1j0tLAzEURoMgtlb_ggT3U3Nvkpkbd6X4goIbXZc0c0NH5sUkIuOvt6CuPg4cDnxC3IJag3XqDgzoggA1KiA0gGsNJZ6gOhNLKCsqjC1hIS5T-lAKK23wQiw0VBVZhKXYb-ojT9wHlkOUvh5aToH7nORXk48yzCk3QcbmMA2pSTIPkvvvuWM58dj6wN3JlfmU8ON8L31KQ2h85lpGH_IwpStxHn2b-PpvV-L98eFt-1zsXp9etptdMYKiXHhDVmmNpQbL_oDkgDxFChBL4xxh0LU3UWlnbQCranLEaAmdKbVHpVfi5rc7fh46rvfj1HR-mvf_T_UP5XBV7Q</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>Ferreira, Danielle Portella</creator><creator>Chaves, Célia Regina Moutinho de Miranda</creator><creator>Costa, Ana Carolina Carioca da</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><orcidid>https://orcid.org/0000-0002-9456-3319</orcidid><orcidid>https://orcid.org/0000-0002-2659-720X</orcidid><orcidid>https://orcid.org/0000-0002-6727-188X</orcidid></search><sort><creationdate>201912</creationdate><title>Adherence of adolescents with cystic fibrosis to enzyme replacement therapy: associated factors</title><author>Ferreira, Danielle Portella ; Chaves, Célia Regina Moutinho de Miranda ; Costa, Ana Carolina Carioca da</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p108t-a48503326315eab28918a8f8c1f649982c3da4f03955c150d898e25829463a203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>por</language><creationdate>2019</creationdate><topic>Adolescent</topic><topic>Child</topic><topic>Cross-Sectional Studies</topic><topic>Cystic Fibrosis - diagnosis</topic><topic>Cystic Fibrosis - therapy</topic><topic>Early Diagnosis</topic><topic>Enzyme Replacement Therapy - statistics & numerical data</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medication Adherence - statistics & numerical data</topic><topic>Surveys and Questionnaires</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ferreira, Danielle Portella</creatorcontrib><creatorcontrib>Chaves, Célia Regina Moutinho de Miranda</creatorcontrib><creatorcontrib>Costa, Ana Carolina Carioca da</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Ciência & saude coletiva</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ferreira, Danielle Portella</au><au>Chaves, Célia Regina Moutinho de Miranda</au><au>Costa, Ana Carolina Carioca da</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adherence of adolescents with cystic fibrosis to enzyme replacement therapy: associated factors</atitle><jtitle>Ciência & saude coletiva</jtitle><addtitle>Cien Saude Colet</addtitle><date>2019-12</date><risdate>2019</risdate><volume>24</volume><issue>12</issue><spage>4717</spage><pages>4717-</pages><eissn>1678-4561</eissn><abstract>This article sets out to evaluate the prevalence and factors associated with adherence to enzyme replacement therapy among adolescents with cystic fibrosis. It is a cross-sectional, descriptive and observational study. Sociodemographic and clinical data were collected. The instruments used to assess adherence were: the Morisky-Green questionnaire and medication dispensation at the pharmacy, and interviews with structured questionnaires for the associated factors. Forty-four adolescents were interviewed. According to the method of the pharmacy medication dispensation analysis and the Morisky-Green questionnaire, the adherence of 45.5% and 11.4% was found, respectively. The higher adherence was observed in those with early diagnosis and the lowest in older adolescents and girls. The factors with the highest prevalence of non-adherence were: not taking enzymes when eating out of the home; only taking enzymes with major meals; normal lung function; with severe and very severe obstruction. The prevalence of adhesion to enzymes was low. Information related to the disease and treatment should be improved, especially among older adolescents and with impairment of lung function, with the creation of strategies and longitudinal studies to identify factors that interfere with adherence.</abstract><cop>Brazil</cop><pmid>31778521</pmid><doi>10.1590/1413-812320182412.31622017</doi><orcidid>https://orcid.org/0000-0002-9456-3319</orcidid><orcidid>https://orcid.org/0000-0002-2659-720X</orcidid><orcidid>https://orcid.org/0000-0002-6727-188X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1678-4561 |
ispartof | Ciência & saude coletiva, 2019-12, Vol.24 (12), p.4717 |
issn | 1678-4561 |
language | por |
recordid | cdi_pubmed_primary_31778521 |
source | SciELO Brazil; Publicly Available Content Database |
subjects | Adolescent Child Cross-Sectional Studies Cystic Fibrosis - diagnosis Cystic Fibrosis - therapy Early Diagnosis Enzyme Replacement Therapy - statistics & numerical data Female Humans Male Medication Adherence - statistics & numerical data Surveys and Questionnaires Young Adult |
title | Adherence of adolescents with cystic fibrosis to enzyme replacement therapy: associated factors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T23%3A03%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adherence%20of%20adolescents%20with%20cystic%20fibrosis%20to%20enzyme%20replacement%20therapy:%20associated%20factors&rft.jtitle=Ci%C3%AAncia%20&%20saude%20coletiva&rft.au=Ferreira,%20Danielle%20Portella&rft.date=2019-12&rft.volume=24&rft.issue=12&rft.spage=4717&rft.pages=4717-&rft.eissn=1678-4561&rft_id=info:doi/10.1590/1413-812320182412.31622017&rft_dat=%3Cpubmed%3E31778521%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p108t-a48503326315eab28918a8f8c1f649982c3da4f03955c150d898e25829463a203%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/31778521&rfr_iscdi=true |